SKN  | NuScale Power Stock Faces Downside Pressure as UBS Warns of Delays and Cash Burn

Key Takeaways

• UBS downgraded NuScale Power from Neutral to Sell and cut its price target from $10 to $6, implying approximately 30% downside from the stock’s current level.
• UBS expects NuScale to burn roughly $700 million in cash between 2026 and 2028 while remaining unprofitable through 2030.
• The core concern is execution: UBS assumes only one NuScale project reaches groundbreaking by 2028, while firm customer commitments remain limited and the company continues to face delays.

NuScale Power is facing renewed pressure after UBS delivered a sharply more cautious assessment of the small modular reactor developer, cutting its price target to $6 from $10 and downgrading the stock from Neutral to Sell.

The downgrade centers on the gap between the market’s expectations for NuScale’s future commercial deployment and what UBS believes the company can realistically deliver. Construction timelines, limited customer commitments and substantial projected cash consumption are becoming increasingly important considerations for investors.

For HNWIs and family offices considering exposure to emerging nuclear-energy technologies, the NuScale case illustrates the difference between the long-term potential of a strategic technology and the near-term financial requirements needed to commercialize it.

Construction Delays Are Central to the UBS Bear Case

UBS expects NuScale to face a construction timeline of more than five years and assumes that only one project will break ground by 2028.

That pace is viewed as insufficient compared with competitors moving closer to actual construction. In the small modular reactor market, project execution is particularly important because technological validation alone does not create meaningful revenue. Commercial deployment requires regulatory progress, financing, customers and physical construction to converge.

UBS also highlighted the lack of firm customer commitments. Without signed agreements, the timing and scale of future revenue remain difficult to establish, increasing the sensitivity of NuScale’s valuation to project-related headlines.

The setbacks surrounding the RoPower project in Romania and limited progress on the Tennessee Valley Authority relationship further contribute to the uncertainty.

Cash Burn Creates an Additional Financing Risk

NuScale’s financial profile adds another layer to the investment case. UBS estimates that the company could consume approximately $700 million in cash between 2026 and 2028.

The concern is particularly significant because NuScale remains years away from generating substantial commercial revenue. The company recorded negative EBITDA of approximately $224 million over the trailing twelve months, indicating that cash consumption is already a central feature of its current operating model.

NuScale also launched a $750 million at-the-market stock offering, with UBS Securities and B. Riley Securities among the firms involved in the program. While such an offering provides additional financing flexibility, it also introduces potential dilution for existing shareholders.

For wealth investors, this creates an important distinction between funding availability and financial sustainability. Access to capital can support development, but repeated equity issuance can reduce the economic value represented by each existing share.

Valuation Expectations May Be Ahead of Operating Reality

UBS identifies a significant gap between the earnings expectations embedded in the stock price and its own projections.

At the current valuation, the market appears to be pricing in approximately $124 million of 2028 EBITDA, while UBS estimates only $29 million. That difference represents a substantial disagreement over the speed at which NuScale can transition from development to commercial profitability.

The issue is not simply whether NuScale eventually generates revenue. UBS expects revenue to increase from $185 million in 2028 to $924 million by 2030, but still expects the company to remain unprofitable through 2030.

This means investors are being asked to support a valuation based heavily on future execution well before the company demonstrates sustained profitability.

Analysts Remain Divided on NuScale’s Long-Term Potential

UBS’s bearish assessment is not universally shared. B. Riley recently reduced its price target from $19 to $15 but maintained a Buy rating.

B. Riley attributed the target reduction primarily to a larger share count and a broader valuation reset across the sector rather than a fundamental deterioration in NuScale’s business outlook.

That divergence illustrates the unusually wide range of assumptions surrounding the company. Bulls continue to focus on the long-term opportunity for small modular reactors and potential commercial adoption, while UBS is placing greater weight on construction timelines, financing requirements and the absence of firm customer commitments.

NuScale’s second-quarter 2026 results further demonstrate the early stage of the business. The company’s per-share results were broadly in line with expectations, but revenue was only $0.1 million, compared with $8.1 million a year earlier.

Strategic Outlook for Global Wealth Investors

NuScale remains exposed to a potentially significant long-term opportunity as governments and energy companies evaluate nuclear power as a source of reliable, lower-carbon electricity. However, the investment thesis currently depends heavily on future project execution.

For HNWIs and family offices, the principal risks are therefore not limited to nuclear technology itself. Construction delays, customer concentration, regulatory milestones, capital requirements and shareholder dilution can all influence the path from technological development to commercial cash flow.

Until major customer agreements and physical project milestones become more tangible, NuScale’s valuation is likely to remain highly sensitive to changes in expectations.

Closing Insights

UBS’s downgrade highlights the financial and execution challenges confronting NuScale Power as it attempts to commercialize its small modular reactor technology. The $6 price target reflects concerns that project deployment may take longer than investors expect, while approximately $700 million of projected cash burn through 2028 creates additional financing pressure.

The bullish counterargument remains centered on the long-term nuclear opportunity, as reflected in B. Riley’s continued Buy rating. But for wealth investors, the immediate question is whether NuScale can convert technological potential into firm customer commitments, construction milestones and eventually sustainable profitability. Until those milestones become clearer, the stock remains a high-execution-risk exposure within the emerging nuclear-energy sector.

For a confidential discussion regarding retail banking strategy, insurance distribution models, customer loyalty ecosystems, digital financial services, or cross-border financial innovation opportunities, contact our senior advisory team.